APA (7th ed.) Citation

CJ, F., BF, K., J, A., OW, T., MS, M., Jr, B. W., . . . D, B. (2004). Breast cancer chemoprevention phase I evaluation of biomarker modulation by arzoxifene, a third generation selective estrogen receptor modulator. Clinical cancer research : an official journal of the American Association for Cancer Research, 10(16), 5403. https://doi.org/10.1158/1078-0432.CCR-04-0171

Chicago Style (17th ed.) Citation

CJ, Fabian, et al. "Breast Cancer Chemoprevention Phase I Evaluation of Biomarker Modulation by Arzoxifene, a Third Generation Selective Estrogen Receptor Modulator." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 10, no. 16 (2004): 5403. https://doi.org/10.1158/1078-0432.CCR-04-0171.

MLA (9th ed.) Citation

CJ, Fabian, et al. "Breast Cancer Chemoprevention Phase I Evaluation of Biomarker Modulation by Arzoxifene, a Third Generation Selective Estrogen Receptor Modulator." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 10, no. 16, 2004, p. 5403, https://doi.org/10.1158/1078-0432.CCR-04-0171.